Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Amphastar Pharmaceuticals (AMPH) Return on Assets (2016 - 2025)

Amphastar Pharmaceuticals (AMPH) has 12 years of Return on Assets data on record, last reported at 0.07% in Q3 2025.

  • For Q3 2025, Return on Assets fell 3.0% year-over-year to 0.07%; the TTM value through Sep 2025 reached 0.07%, down 3.0%, while the annual FY2024 figure was 0.11%, 1.0% down from the prior year.
  • Return on Assets reached 0.07% in Q3 2025 per AMPH's latest filing, down from 0.09% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.14% in Q4 2022 and bottomed at 0.0% in Q1 2021.
  • Average Return on Assets over 5 years is 0.09%, with a median of 0.1% recorded in 2023.
  • Peak YoY movement for Return on Assets: decreased -13bps in 2021, then grew 12bps in 2022.
  • A 5-year view of Return on Assets shows it stood at 0.1% in 2021, then surged by 47bps to 0.14% in 2022, then tumbled by -37bps to 0.09% in 2023, then rose by 19bps to 0.11% in 2024, then tumbled by -33bps to 0.07% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.07% in Q3 2025, 0.09% in Q2 2025, and 0.09% in Q1 2025.